CLINICAL EFFECTIVENESS AND SAFETY PROFILE OF LITHIUM-ANTIPSYCHOTIC AND VALPROATE-ANTIPSYCHOTIC COMBINATIONS IN BIPOLAR DISORDER: A NARRATIVE REVIEW
DOI:
https://doi.org/10.51878/healthy.v6i1.15423Keywords:
Bipolar, Mood Stabilizers, Antipsikotik, Efektivitas, Profil KeamananAbstract
ABSTRACT
Bipolar disorder is a chronic psychiatric condition characterized by recurrent mood episodes that may impair daily functioning and require long-term pharmacological treatment. Combination therapy involving mood stabilizers and second-generation antipsychotics (SGAs) is commonly used in the management of bipolar disorder, particularly lithium-SGA and valproate-SGA combinations. This narrative review aimed to analyze and compare the clinical effectiveness, functional outcomes, and safety profiles of these two combinations in patients with bipolar disorder. A literature search was conducted using PubMed, ScienceDirect, and Scopus for articles published between 2016 and 2026. Of the 2,482 articles identified, 31 met the initial selection criteria, and seven were subsequently included in this review. The findings indicated that both lithium-SGA and valproate-SGA combinations provided clinical benefits in controlling manic symptoms and preventing mood episode recurrence, although their effectiveness varied according to the treatment phase. Lithium-SGA combinations demonstrated benefits in the management of acute manic and mixed episodes. However, evidence regarding functional outcomes remained limited and varied across studies. Both combinations also presented distinct safety considerations. Therefore, treatment selection should be individualized according to the patient's clinical condition, therapeutic goals, expected treatment response, safety profile, and monitoring requirements. In conclusion, both combinations may serve as therapeutic options for bipolar disorder, with their selection requiring careful consideration of the potential clinical benefits and associated risks.
ABSTRAK
Gangguan bipolar merupakan gangguan psikiatri kronis yang ditandai dengan episode perubahan suasana hati berulang, sehingga dapat mengganggu fungsi sehari-hari dan memerlukan pengobatan farmakologis jangka panjang. Kombinasi penstabil suasana hati dengan antipsikotik generasi kedua (second-generation antipsychotics/SGA) sering digunakan dalam penatalaksanaan gangguan bipolar, terutama kombinasi lithium-SGA dan valproat-SGA. Tinjauan naratif ini bertujuan untuk menganalisis dan membandingkan efektivitas klinis, luaran fungsional, serta aspek keamanan kedua kombinasi tersebut pada pasien gangguan bipolar. Penelusuran literatur dilakukan melalui basis data PubMed, ScienceDirect, dan Scopus terhadap artikel yang diterbitkan pada periode 2016–2026. Dari 2.482 artikel yang teridentifikasi, sebanyak 31 artikel memenuhi kriteria seleksi awal, kemudian tujuh artikel dipilih untuk dianalisis dalam tinjauan ini. Hasil menunjukkan bahwa kombinasi lithium-SGA dan valproat-SGA sama-sama memberikan manfaat klinis dalam mengendalikan gejala mania dan mencegah kekambuhan episode suasana hati, meskipun efektivitasnya dapat berbeda berdasarkan fase pengobatan. Kombinasi lithium-SGA menunjukkan manfaat pada penanganan episode mania akut dan episode campuran. Namun, bukti mengenai luaran fungsional masih terbatas dan menunjukkan hasil yang bervariasi. Kedua kombinasi juga memiliki pertimbangan keamanan yang berbeda sehingga pemilihan terapi perlu disesuaikan dengan kondisi klinis pasien, tujuan pengobatan, respons yang diharapkan, profil keamanan, serta kebutuhan pemantauan. Dengan demikian, pemilihan kombinasi lithium-SGA atau valproat-SGA harus dilakukan secara individual berdasarkan pertimbangan manfaat dan risiko terapi.
References
Afitriyani, N. A., Dwinta, E., Putri, I. R. R., & Astuti, W. S. (2023). Analisis efektivitas biaya (cost effectiveness analysis) penggunaan antipsikotik monoterapi atipikal dengan kombinasi atipikal dan tipikal pada pasien rawat inap skizofrenia di Rumah Sakit Jiwa Grhasia Yogyakarta. JIIS (Jurnal Ilmiah Ibnu Sina): Ilmu Farmasi dan Kesehatan, 8(3), 46–56. https://doi.org/10.36387/jiis.v8i3.1656
Carli, M., Weiss, F., Grenno, G., Ponzini, S., Kolachalam, S., Vaglini, F., Viaggi, C., Pardini, C., Tidona, S., Longoni, B., Maggio, R., & Scarselli, M. (2023). Pharmacological strategies for bipolar disorders in acute phases and chronic management with a special focus on lithium, valproic acid, and atypical antipsychotics. Current Neuropharmacology, 21, 935–950.
https://doi.org/10.2174/1570159X21666230224102318
Greil, W., de Bardeci, M., Müller-Oerlinghausen, B., Nievergelt, N., Stassen, H., Hasler, G., & Schoretsanitis, G. (2023). Controversies regarding lithium-associated weight gain: Case–control study of real-world drug safety data. International Journal of Bipolar Disorders, 11(1), 34. https://doi.org/10.1186/s40345-023-00313-8
Gitlin, M., & Bauer, M. (2024). Lithium: Current state of the art and future directions. International Journal of Bipolar Disorders, 12(1), 40.
https://doi.org/10.1186/s40345-024-00362-7
Hidayaturrahmi, H., Putra, T. R. I., Mizfaruddin, M., Mulia, V. D., Humaira, D., & Al-Muchtari, T. A. Z. (2023). Hubungan kadar low density lipoprotein dengan luaran fungsional pada stroke iskemik. Majalah Kedokteran Neurosains Perhimpunan Dokter Spesialis Saraf Indonesia, 39(4), 145–148. https://doi.org/10.52386/neurona.v39i4.421
Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus, 21(4), 344–353. https://doi.org/10.1176/appi.focus.20230009
Kim, H. K., Banik, S., Husain, M. I., Tang, V., Levitan, R., Daskalakis, Z. J., & Kloiber, S. (2023). Systematic review of structured care pathways in major depressive disorder and bipolar disorder. BMC Psychiatry, 23(1), 85. https://doi.org/10.1186/s12888-022-04379-z
Kishi, T., Ikuta, T., Matsuda, Y., Sakuma, K., Okuya, M., Mishima, K., & Iwata, N. (2021). Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: A systematic review and network meta-analysis of randomized controlled trials. Molecular Psychiatry, 26(8), 4146–4157. https://doi.org/10.1038/s41380-020-00946-6
Lähteenvuo, M., Paljärvi, T., Tanskanen, A., Taipale, H., & Tiihonen, J. (2023). Real-world effectiveness of pharmacological treatments for bipolar disorder: Register-based national cohort study. The British Journal of Psychiatry, 223, 456–464.
https://doi.org/10.1192/bjp.2023.75
Lesmana, C. B. J., & Wirawan, I. M. A. (2023). Association of collaborative care model and quality of life in schizophrenia. Jurnal Widya Medika, 9(2), 91–103. https://doi.org/10.33508/jwm.v9i2.3393
Li, P. Y., Wang, M. T., Jeng, J. S., Lin, T. C., Hung, T. Y., Chen, Y. H., & Liou, Y. J. (2026). Comparative effectiveness of lithium- vs. valproate-based combinations with atypical antipsychotics in preventing rehospitalization after a first manic episode of bipolar I disorder. Bipolar Disorders, 28(7), e70184. https://doi.org/10.1111/bdi.70184
Mari, J., Dieckmann, L. H. J., Prates-Baldez, D., Haddad, M., Rodrigues Da Silva, N., & Kapczinski, F. (2024). The efficacy of valproate in acute mania, bipolar depression and maintenance therapy for bipolar disorder: An overview of systematic reviews with meta-analyses. BMJ Open, 14(11). https://doi.org/10.1136/bmjopen-2024-087999
Oliva, V., Fico, G., Prisco, M. De, Gonda, X., Rosa, A. R., & Vieta, E. (2025). Bipolar disorders: An update on critical aspects. The Lancet Regional Health – Europe, 48, 101135. https://doi.org/10.1016/j.lanepe.2024.101135
Pagedongan, D. N. P., & Astuti, K. W. (2025). Efektivitas terapi kombinasi metformin dan glimepiride pada pasien diabetes mellitus tipe 2: Tinjauan literatur. Jurnal Praba: Jurnal Rumpun Kesehatan Umum, 3(3), 13–24.
https://doi.org/10.62027/praba.v3i3.493
Park, S. A., Son, S., Tae, B. S., Choi, H., Jeong, J. H., Yoon, H. K., Shin, C., Kwon, D. Y., & Ko, Y. H. (2026). Long-term treatment with lithium, valproate, and atypical antipsychotics on suicide risk in patients with bipolar disorder: A nationwide retrospective cohort study. Journal of Affective Disorders, 392, 120264.
https://doi.org/10.1016/j.jad.2025.120264
Ponsoni, A., Branco, L. D., Cotrena, C., Shansis, F. M., & Fonseca, R. P. (2023). A longitudinal study of cognition, functional outcome and quality of life in bipolar disorder and major depression. Applied Neuropsychology: Adult, 30(6), 757–763.
https://doi.org/10.1080/23279095.2021.1979551
Pratiwi, W., Effendi, J., & Biromo, A. R. (2026). Efektivitas kombinasi dual antipsikotik (risperidone dan olanzapine) serta SSRI dalam manajemen gangguan skizoafektif tipe depresif: Laporan kasus. KOLONI, 5(2), 1146–1153.
https://doi.org/10.31004/koloni.v5i2.978
Rahmi, K. A., Khotimah, H., & Rohman, M. S. (2025). Cardiovascular side effects and toxicity of lithium usage in adults: A systematic review of case reports and observational studies. Heart Science Journal, 6(4). https://doi.org/10.21776/ub.hsj.2025.006.04.7
Sofwatussuba, N. K., Setyowati, E., & Besan, E. J. (2025). Rasionalitas penggunaan antipsikotik pada pasien gangguan bipolar disorder di RSUD Dr. Loekmono Hadi Kudus periode Januari–Juni 2024. Nusantara Hasana Journal, 5(3), 349–358.
https://doi.org/10.59003/nhj.v5i3.1586
Wang, X., Ye, F., Zhang, Z., Zhang, Q., & Li, G. (2025). Effects of olanzapine combined with sodium valproate on symptoms, inflammatory markers, and cognitive function in patients with bipolar disorder. Medicine, 104(26), e42803.
https://doi.org/10.1097/MD.0000000000042803
Yee, C. S., Vazquez, G. H., Hawken, E. R., Biorac, A., Tondo, L., & Baldessarini, R. J. (2021). Long-term treatment of bipolar disorder with valproate: Updated systematic review and meta-analyses. Harvard Review of Psychiatry, 29(3), 188–195.
https://doi.org/10.1097/HRP.0000000000000292
Zazula, R., Mohebbi, M., Dodd, S., Dean, O. M., Berk, M., Vargas, H. O., & Nunes, S. O. V. (2022). Cognitive profile and relationship with quality of life and psychosocial functioning in mood disorders. Archives of Clinical Neuropsychology, 37(2), 376–389. https://doi.org/10.1093/arclin/acab054
